.
  • NIFTY 26,046.95 +148.40 (+0.57%)
  • SENSEX 85,267.66 +449.53 (+0.53%)
BSE
NSE

Friday, December 12, 2025 , BSE Sensex : 85,267.66 85,267.66(0.53%) , Adani Ports : 1,522.40 1,522.40(1.28%) , Asian Paints : 2,765.45 2,765.45(-0.49%) , Axis Bank : 1,286.30 1,286.30(1.09%) , Bajaj Finance : 1,017.45 1,017.45(1.15%) , Bajaj Finserv : 2,086.00 2,086.00(1.01%) , Bharat Electron : 389.40 389.40(0.40%) , Bharti Airtel : 2,083.35 2,083.35(1.47%) , Eternal Ltd : 298.00 298.00(2.37%) , HCL Technologies : 1,672.40 1,672.40(0.00%) , HDFC Bank : 1,000.20 1,000.20(0.00%) , Hind. Unilever : 2,261.05 2,261.05(-1.89%) , ICICI Bank : 1,366.00 1,366.00(0.44%) , Infosys : 1,598.75 1,598.75(0.06%) , ITC : 400.50 400.50(-0.63%) , Kotak Mah. Bank : 2,176.45 2,176.45(-0.23%) , Larsen & Toubro : 4,073.70 4,073.70(1.71%) , M & M : 3,678.90 3,678.90(0.38%) , Maruti Suzuki : 16,520.90 16,520.90(1.59%) , NTPC : 325.05 325.05(0.76%) , Power Grid Corpn : 263.60 263.60(-0.42%) , Reliance Industr : 1,556.00 1,556.00(0.72%) , SBI : 962.90 962.90(-0.05%) , Sun Pharma.Inds. : 1,794.30 1,794.30(-0.70%) , Tata Motors PVeh : 347.45 347.45(0.23%) , Tata Steel : 171.90 171.90(3.34%) , TCS : 3,220.15 3,220.15(0.89%) , Tech Mahindra : 1,579.05 1,579.05(0.66%) , Titan Company : 3,880.40 3,880.40(0.95%) , Trent : 4,072.95 4,072.95(0.68%) , UltraTech Cem. : 11,725.05 11,725.05(2.25%) ,

Nifty 50 : 26,046.95 148.40(0.57%) , Adani Enterp. : 2,282.40 4.70(0.21%) , Adani Ports : 1,522.80 18.80(1.25%) , Apollo Hospitals : 7,101.00 91.50(1.31%) , Asian Paints : 2,764.80 -14.60(-0.53%) , Axis Bank : 1,286.10 13.40(1.05%) , Bajaj Auto : 9,015.00 -38.50(-0.43%) , Bajaj Finance : 1,017.30 10.90(1.08%) , Bajaj Finserv : 2,083.10 17.30(0.84%) , Bharat Electron : 389.45 1.95(0.50%) , Bharti Airtel : 2,083.40 30.20(1.47%) , Cipla : 1,517.40 5.10(0.34%) , Coal India : 383.35 -0.65(-0.17%) , Dr Reddy's Labs : 1,279.30 5.80(0.46%) , Eicher Motors : 7,229.00 -27.00(-0.37%) , Eternal Ltd : 298.05 7.10(2.44%) , Grasim Inds : 2,836.70 38.90(1.39%) , HCL Technologies : 1,673.20 0.80(0.05%) , HDFC Bank : 1,001.50 1.20(0.12%) , HDFC Life Insur. : 777.50 2.30(0.30%) , Hind. Unilever : 2,260.60 -45.00(-1.95%) , Hindalco Inds. : 852.10 27.75(3.37%) , ICICI Bank : 1,366.00 6.00(0.44%) , Infosys : 1,598.20 0.20(0.01%) , Interglobe Aviat : 4,860.50 41.50(0.86%) , ITC : 400.10 -2.80(-0.69%) , Jio Financial : 300.75 2.30(0.77%) , JSW Steel : 1,125.50 20.10(1.82%) , Kotak Mah. Bank : 2,176.60 -3.60(-0.17%) , Larsen & Toubro : 4,074.10 70.20(1.75%) , M & M : 3,679.60 14.40(0.39%) , Maruti Suzuki : 16,522.00 274.00(1.69%) , Max Healthcare : 1,081.30 -6.60(-0.61%) , Nestle India : 1,238.30 23.30(1.92%) , NTPC : 325.05 2.45(0.76%) , O N G C : 238.02 -0.39(-0.16%) , Power Grid Corpn : 263.60 -1.20(-0.45%) , Reliance Industr : 1,556.50 11.50(0.74%) , SBI : 963.15 -0.10(-0.01%) , SBI Life Insuran : 2,025.90 19.00(0.95%) , Shriram Finance : 848.00 0.85(0.10%) , Sun Pharma.Inds. : 1,793.50 -13.70(-0.76%) , Tata Consumer : 1,149.30 7.20(0.63%) , Tata Motors PVeh : 347.45 0.80(0.23%) , Tata Steel : 171.89 5.51(3.31%) , TCS : 3,220.50 28.60(0.90%) , Tech Mahindra : 1,578.40 10.20(0.65%) , Titan Company : 3,880.20 35.40(0.92%) , Trent : 4,075.40 27.90(0.69%) , UltraTech Cem. : 11,723.00 251.00(2.19%) , Wipro : 260.60 1.35(0.52%) , Friday, December 12, 2025

Home >> Markets >> Equities >> News - News Details
Hot Pursuit
28-Nov-2025     09:21
Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi

The approved ANDA is a generic version of the US reference listed drug Glyxambi Tablets.

Empagliflozin and Linagliptin Tablets, in a combination, are indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both empagliflozin and linagliptin is appropriate.

Empagliflozin and Linagliptin Tablets will be produced at the group's formulation manufacturing facility at SEZ, Ahmedabad.

Empagliflozin and Linagliptin Tablets had annual sales of USD 215.8 mn in the United States (IQVIA MAT Sept-2025).

The group now has 428 approvals and has so far filed 487 ANDAs since the commencement of the filing process in FY 2003-04.

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in lifesciences through quality healthcare solutions that impact lives.

Zydus Lifesciences reported a 38.12% jump in consolidated net profit to Rs 1,258.60 crore in Q2 FY26, compared with Rs 911.2 crore posted in Q2 FY25. Revenue from operations increased 18.07% year on year (YoY) to Rs 6,037.9 crore in Q2 FY26.

The scrip rose 0.54% to currently trade at Rs 942.35 on the BSE.

Powered by Capital Market - Live News